SERP
Comments:
CPS2 is a valuable tool compound for investigating CDK2 biology and the therapeutic potential of CDK2 degradation. At a concentration of 250 nM and following 6 hours of treatment of NB4 cells, CPS2 induces significant degradation of both CDK2 and AURKA—an important consideration for potential users. The original publication also includes kinome-wide profiling at 1 μM concentration. Given its potent degradation activity, the compound’s inhibitory effects are likely negligible at concentrations below 250 nM. CPS2 exhibits DC₅₀ values in the double-digit nanomolar range across seven different cell lines. Its mechanism of action has been thoroughly validated. A structurally related negative control compound, which is incapable of binding CRBN, is also described in the original study. Overall, CPS2 can be considered one of the best chemical probes currently available (as of April 2025) for studying CDK2.
(last updated:
16 Apr 2025 )